The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of trametinib and anti-PD-1 combo on tumor growth and survival of KRAS-mutant lung cancer by ID1 downregulation.
 
Ander Puyalto Calvo
No Relationships to Disclose
 
María Rodríguez-Remírez
No Relationships to Disclose
 
Ines Lopez
No Relationships to Disclose
 
Maria Olmedo
No Relationships to Disclose
 
Anna Vilalta
No Relationships to Disclose
 
Irati Macaya
No Relationships to Disclose
 
Connor Welch
No Relationships to Disclose
 
Silvestre Vicent
No Relationships to Disclose
 
Alfonso Calvo
No Relationships to Disclose
 
Daniel Ajona
No Relationships to Disclose
 
Ignacio Gil-Bazo
Consulting or Advisory Role - AstraZeneca Spain; Boehringer Ingelheim Spain; Bristol-Myers Squibb/Celgene; Lilly; MSD Oncology; Sanofi
Speakers' Bureau - Guardant Health; Takeda
Travel, Accommodations, Expenses - MSD Oncology; Roche/Genentech